Major deals, including Johnson & Johnson’s $14.6B Intra-Cellular acquisition, signal renewed dealmaking, supported by nearly ...

The Indiana University School of Medicine has canceled its annual LGBTQ+ Health Care Conference, posting the change in a ...

Thryv Therapeutics Inc., a clinical-stage biotechnology company pioneering novel therapies for cardiovascular diseases, is ...

YAVNE, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics ...

This week on “The Top Line,” we break down the biggest stories out of JPM, from J&J’s blockbuster acquisition of ...

Several members of our firm’s life sciences team were on the ground at the 43rd Annual J.P. Morgan Healthcare Conference in ...

Innovations in Patient Experience: A Modern Healthcare Event is a conference designed to showcase best practices for ...

The efforts are aimed at keeping the roughy 20,000 health care executives and investors safe as well as highlighting downtown San Francisco's recovery progress. San Francisco and its hotel ...

I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision ...

Medicenna Therapeutics Corp. ("Medicenna” or the "Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy co ...

The annual conference is intended for health care professionals, patients and community groups to improve health care and identify unique health risks for LGBTQ+ individuals. The Indianapolis Business ...